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INTRODUCTION
The gastrointestinal tract is the most commonly involved
extranodal site in non-Hodgkin’ s lymphoma (1, 2). However,
the esophageal involvement by lymphoma is the rarest event,
accounting for less than 1% of patients with lymphoma (1-3).
Since Isaacson and Wright introduced the concept of mucosa-
associated lymphoid tissue (MALT) lymphoma in 1984 (4),
there have been many reports regarding primary gastrointesti-
nal MALT lymphoma, especially primary gastric MALT lym-
phoma. To our knowledge, only one case of primary esophageal
MALT lymphoma has been reported (5). Recent advancement
in endoscopic ultrasonography (EUS) provides detailed struc-
tural abnormalities and depth of invasion in various gastroin-
testinal diseases including gastric lymphoma (6). Usually, gas-
tric MALT lymphoma presents itself as a thickening of the
mucosa and submucosa layer in the gastric wall, or discrete
tumor masses; however, nearly all cases show infiltration of
the mucosa (7, 8). We report a case of primary esophageal
MALT lymphoma presenting itself as a large submucosal tum-
or (SMT), which was examined by endoscopic ultrasonogra-
phy. 
CASE REPORT
A 61-yr-old man was referred to Soon Chun Hyang Uni-
versity hospital for evaluation of an esophageal SMT that had
been detected incidentally by endoscopy. The patient denied
dysphagia and any systemic symptoms. He had a history of
pulmonary tuberculosis, which had been completely healed
after a long-term medication (isoniazid, rifampin, ethambu-
tol, and pyrazinamide for 9 months) 15 yr before. He also had
a history of syphilis, which had been completely treated one
year before. He had been taking a Comthyroid
� (a combina-
tion of synthetic hormones; levothyroxine 0.05 mg and lio-
thyronine 0.0125 mg) daily for the past 10 months because
of an autoimmune thyroiditis. His blood sugar level was slight-
ly high, but had been well controlled by diet control and exer-
cise. He had a history of alcohol abuse for over 20 yr. He had
a 20-pack-year smoking history. Physical examination revealed
no abnormal finding except slightly pale conjunctivae. Lab-
oratory data included white blood cell count 7,100/ L (normal
range, 4,000-10,000/ L), hemoglobin value 10.3 g/dL (normal
range, 13-17 g/dL), MCV 79.9 fL (normal range, 81-96 fL),
and platelet count 307×103/ L (normal range, 130-450×
103/ L). Fasting blood sugar level was 93 mg/dL (normal
range, 70-110 mg/dL) with HbA1c of 7.0% (normal range,
3.8-5.4%). Thyroid function test revealed TSH 1.89  U/mL
(normal range, 0.25-4.0  U/mL), T3 uptake 27.9% (normal
range, 23-34%), T3 116.2 ng/dL (normal range, 60-190 ng/
dL), and T4 7.73  g/dL (normal range, 4.5-11 g/dL). Both
thyroglobulin antibodies and microsomal antibodies were pos-
itive (1.49 U/mL and 2.2 U/mL, respectively; normal range,
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A Case of Primary Esophageal B-cell Lymphoma of MALT type, 
Presenting as a Submucosal Tumor
The primary esophageal lymphoma is extremely rare, and shows various mor-
phologic characteristics. Only a single case of mucosa-associated lymphoid tissue
(MALT) type lymphoma confined to the esophagus has been reported in the lit-
erature. A 61-yr-old man was referred to our hospital for evaluation of an esophageal
submucosal tumor (SMT) that had been detected incidentally by endoscopy. He
had a history of pulmonary tuberculosis with long-term anti-tuberculosis medica-
tion 15 yr before, and also had a history of syphilis, which had been treated one
year before. He had been taking a synthetic thyroid hormones for the past 10
months because of an autoimmune thyroiditis. Endoscopy showed a longitudinal
round and tubular shaped smooth elevated lesion, which was covered with intact
mucosa and located at the mid to distal esophagus, 31 cm to 39 cm from the
incisor teeth. Endoscopic ultrasonography (EUS) showed a huge longitudinal
growing intermediate- to hypo-echoic mass located in the submucosal layer with
internal small, various sized honeycomb-like anechoic lesions suggesting germinal
centers. Subsequently, he underwent a surgery, which confirmed the mass as a
primary esophageal low-grade B-cell lymphoma of MALT type.
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<0.3 U/mL for both). 
Initial endoscopy showed a longitudinal round and tubu-
lar shaped smooth elevated lesion, which was covered with
intact normal mucosa and located at the mid to distal esoph-
agus, 31 cm to 39 cm (2 cm from the Z-line) from the incisor
teeth. There was no such finding as reflux esophagitis or Bar-
rett’ s esophagus (Fig. 1). EUS showed an intermediate echoic
mass, which was located in the deep mucosal and submucos-
al layer and measured 2×8 cm. The mass was well demarcat-
ed, lobulated, and had multiple small anechoic lesions (honey-
comb in appearance) within its solid portion (Fig. 2). A small
round hypoechoic mass of 1.0 cm in diameter was also shown
around the esophageal wall from the aorticopulmonary (AP)
window, suggesting regional lymph node hyperplasia. These
findings suggested the possibility of the esophageal stromal
cell tumor or cavernous hemangioma. He was discharged with-
out further evaluation including EUS-guided aspiration cytol-
ogy for the proper tissue diagnosis. 
There was no change in EUS findings 6 months after dis-
charge. Barium esophagogram showed a smooth elongated
protruded mass lesion in the distal esophagus, 2 cm above the
esophagogastric junction, and this finding was compatible
with a stromal tumor (Fig. 3). Dynamic chest computed tomo-
graphy showed a well-defined, poorly enhanced mass in the
distal esophagus, suggesting an esophageal SMT. Two small
lymph nodes were also detected in the paraseptal region and
AP window. There was a centrilobular and paraseptal emphy-
sema. Abdominal ultrasonography showed normal abdomi-
nal organs, except for a mild fatty liver. 
Surgical resection was performed under the impression of
esophageal stromal cell tumor. After exposure of distal esoph-
agus and confirmation of the exact tumor site, longitudinal
myotomy was done along the tumor and we tried to separate
the tumor mass from the mucosa. However, since the tumor
was unusual for stromal cell tumor and had different patho-
logic characteristics, it was impossible to separate the tumor
Fig. 1. Endoscopic view of the large longitudinal round mass with
normal overlying mucosa in mid and distal esophagus. 
Fig. 2. Endoscopic ultrasonogram showing a well-demarcated, 2
×1.5×8 cm-sized, lobulated mass with intermediate echoic pat-
tern and honeycomb-like multiple small anechoic lesions, origi-
nating from the third hyperechoic layer (submucosa), consistent
with a submucosal tumor such as esophageal stromal cell tumor
or cavernous hemangioma.
Fig. 3. Esophagogram showing a large submucosal tumor (arrows)
with luminal narrowing, about 10 cm in length, in mid and distal
esophagus.122 C.S. Shim, J.S. Lee, J.O. Kim, et al.
mass from the mucosa. We removed the elongated tumor mass
with underlying mucosa and closed the remaining mucosa
and muscle separately layer by layer, and then covered the myo-
tomy site with a pleural flap. The gross examination of the
surgical specimen revealed a well-circumscribed multinodu-
lar grayish white mass (6×2×1.5 cm), which was covered
by normal esophageal mucosa on one side. The cut surface
was creamy yellow and lobulated in appearance. Histological-
ly the esophageal mucosa was unremarkable. The lamina pro-
pria and the submucosa were replaced by dense infiltration
of lymphoid cells. These lymphoid cells were arranged in large
follicles with occasional germinal centers. Proliferating lym-
phoid cells were relatively monotonous centrocyte-like cells
with irregular nuclear membrane and abundant clear cyto-
plasm (Fig. 4). Immunohistochemistry disclosed positive stain-
ing for CD20, Bcl 2, and CD10 and negative staining for Bcl
6, CD3, CD5, and cycline D1. These cells showed a monoclon-
al restriction pattern for the kappa light chain on immunos-
taining and a positive monoclonal band for immunoglobulin
heavy chain gene rearrangement (Fig. 5). These findings were
consistent with a low-grade B-cell lymphoma of MALT type.
Regional lymph nodes showed reactive hyperplasia. 
Follow-up endoscopy with rapid urease test after surgery
showed mild atrophic gastritis with Helicobacter pylori infection,
so he received the modified triple therapy (clarithromycin,
amoxicillin, and proton pump inhibitor for 1 week) and erad-
ication of H. pylori was confirmed one month later.
DISCUSSION
MALT lymphoma is a distinct subgroup of non-Hodgkin’s
lymphoma with particular clinicopathologic characteristics.
Fig. 4. (A) Histologic section disclosed proliferation of lymphoid cells in a large follicular pattern with occasional germinal center formation
(H&E, ×40). (B) Proliferating lymphoid cells had central nuclei with irregular nuclear membrane and abundant clear cytoplasm (H&E,×
1,000).
A B
Fig. 5. Molecular analysis of immunoglobulin heavy chain gene
rearrangement by polymerase chain reaction using FR3A-LJH as
a primary PCR (Lane A) and using FR3A-VLJH as a secondary
PCR (Lane B). A monoclonal dominant band corresponding to a
monoallelic clonal rearrangement was noted on 90-100 bp (Lane
B). Lane C, beta-globin control; Lane D, molecular markers. 
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The gastrointestinal tract is the most commonly involved site,
but it may be observed in the lungs, breast, bladder, conjuncti-
va, kidney, liver, skin, salivary glands, thyroid, and thymus (9).
Organized MALT within the gastrointestinal tract is dis-
tributed throughout the small intestine, appendix, and colo-
rectum, forming Payer’ s patches, but is normally not found
within the stomach mucosa, esophageal mucosa, salivary gland,
or thyroid. However, MALT lymphoma usually develops from
acquired MALT rather than the primary organized MALT.
These acquired MALT tend to appear in patients with a his-
tory of autoimmune diseases or chronic inflammatory disor-
ders. In the stomach, this lesion is induced by long-standing
gastric infection with H. pylori and gastric MALT lymphoma
may eventually develop as a result of persistent immunolog-
ical stimulation. Acquired MALT also develops within the
salivary glands, thyroid or lungs as a result of myoepithelial
sialoadenoiditis, due to Sjogren’s syndrome, Hashimoto thy-
roiditis, and interstitial lymphoid pneumonia (9, 10).
In our patient, the MALT lymphoma developed in the sub-
mucosal layer and was found only in the mucosa and submu-
cosal layer of the esophagus definitely apart from the cardia
although he had the H. pylori infection in his stomach. Atyp-
ical hyperplastic lymphoproliferative responses are known to
occur due to Epstein-Barr virus, human immunodeficiency
virus (HIV), human T-cell leukemia/lymphoma virus type I
(HTLV-I), and certain drugs, and in post-transplant organ reci-
pients, in autoimmune disorders, and in acquired or genetic
hypogammaglobulinemias (11). In our patient, we could not
detect the exact cause of esophageal MALT lymphoma, how-
ever, there were potential risk factors, such as an autoimmune
disorder, drugs, and chronic periesophageal inflammation,
which were supported by the presence of autoimmune thy-
roiditis, history of long-term anti-tuberculosis medication,
and treatment of syphilis, respectively. 
Usually CD10 expression has been described as the sensi-
tive and specific marker of follicular center cell lymphoma.
Recently the specificity of CD10 expression was challenged
due to observation of CD10 expression in the neoplastic T
cells of angioimmunoblastic T-cell lymphoma (12). There-
fore CD10/Bcl-6 coexpression is regarded as a reliable mark-
er for follicular center B cell differentiation (13). Though CD10
was positive in our patient, the possibility of malignant lym-
phoma of follicular center cell origin is less likely because CD
10 expression is not accompanied by Bcl-6.
The major finding of low-grade gastric MALT lymphoma
on EUS, as has been suggested in many reports, is the thick-
ening of the wall layer, especially the first to the third layer
(8, 9, 14, 15). Some cases show discrete tumor masses destroy-
ing the mucosal layer. However, our case presented itself as
a well-demarcated SMT-like intermediate- to hypo-echoic mass
located in the submucosal layer, which misled us to an impres-
sion of esophageal stromal cell tumor or cavernous heman-
gioma. Internal, small, various sized, honeycomb-like anechoic
lesions may suggest germinal centers. In general, the lym-
phomatous involvement of the gastric wall proceeds mainly
by longitudinal (or horizontal) growth within the wall, while
the growth of cancer is predominantly vertical with early inva-
sion of the deep wall. Mucosal involvement in lymphoma is
often less extensive than the infiltration of underlying layers
(16). From these observations, we considered the EUS findings
of our case to suggest a low-grade lymphoma, because the
lymphoma of the patient had developed in the submucosal
layer and was found only in the mucosa and submucosal layer
of the esophagus, representing a longitudinal SMT.
Another case of primary esophageal MALT lymphoma re-
ported also presented itself as a SMT-like lesion, which was
very similar to our case, despite the lack of description of patho-
logic findings (5). To our knowledge, these two cases are the
only reported cases of primary esophageal MALT lymphoma,
which showed a predominant esophageal involvement with-
out peripheral or mediastinal lymph node involvement, as
well as splenic or hepatic involvement, and a normal white
cell count (17). This SMT-like growth might be a character-
istic of primary esophageal MALT lymphoma. 
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